1. Denosumab-associated ONJ: new contraindication

   News item 05 September 2015 Pages: 1 - 1

2. Label advisory statements required for OTC diclofenac in New Zealand

   News item 05 September 2015 Pages: 2 - 2

3. Lareb: increased ADRs associated with oxaliplatin

   Review 05 September 2015 Pages: 3 - 3

4. Picato gel may cause anaphylaxis or shingles

   News item 05 September 2015 Pages: 4 - 4

5. FDA guidance on OTC paediatric oral paracetamol

   News item 05 September 2015 Pages: 5 - 5

6. Use of testosterone for age-related hypogonadism: FDA concerns

   Comment 05 September 2015 Pages: 6 - 6

7. Clozapine: early haematological abnormalities are transient

   Clinical study 05 September 2015 Pages: 7 - 7

8. Methylphenidate safer than atomoxetine for ADHD in Italy

   Clinical study 05 September 2015 Pages: 8 - 8

9. Seven days of H. pylori therapy least effective, better tolerated

   Clinical study 05 September 2015 Pages: 9 - 9

10. Severe hypersensitivity reactions with prescription drugs in Germany

    Clinical study 05 September 2015 Pages: 10 - 10

11. Switching to Stribild: good strategy

    Clinical study 05 September 2015 Pages: 11 - 11

12. Acenocoumarol

    Case report 05 September 2015 Pages: 12 - 12

13. Adalimumab

    Case report 05 September 2015 Pages: 13 - 13

14. Adalimumab

    Case report 05 September 2015 Pages: 14 - 14

15. Adalimumab

    Case report 05 September 2015 Pages: 15 - 15

16. Adalimumab

    Case report 05 September 2015 Pages: 16 - 16

17. Adalimumab withdrawal

    Case report 05 September 2015 Pages: 17 - 17

18. Adalimumab/etanercept/infliximab/itraconazole

    Case report 05 September 2015 Pages: 18 - 18

19. Adapalene

    Case report 05 September 2015 Pages: 19 - 19

20. Adefovir dipivoxil/tenofovir disoproxil fumarate

    Case report 05 September 2015 Pages: 20 - 20

21. Alitretinoin

    Case report 05 September 2015 Pages: 21 - 21

22. Allopurinol

    Case report 05 September 2015 Pages: 22 - 22

23. Alprazolam/baclofen/diazepam

    Case report 05 September 2015 Pages: 23 - 23

24. Amiodarone

    Case report 05 September 2015 Pages: 24 - 24

25. Amiodarone

    Case report 05 September 2015 Pages: 25 - 25

26. Amiodarone

    Case report 05 September 2015 Pages: 26 - 26

27. Amoxicillin/cefalexin

    Case report 05 September 2015 Pages: 27 - 27

28. Amphotericin B liposomal

    Case report 05 September 2015 Pages: 28 - 28

29. Anastrozole/letrozole

    Case report 05 September 2015 Pages: 29 - 29

30. Antineoplastics/melphalan

    Case report 05 September 2015 Pages: 30 - 30

31. Antipsychotics

    Case report 05 September 2015 Pages: 31 - 31

32. Antipsychotics

    Case report 05 September 2015 Pages: 32 - 32

33. Antituberculars/immunosuppressants

    Case report 05 September 2015 Pages: 33 - 33

34. Apixaban

    Case report 05 September 2015 Pages: 34 - 34

35. Aripiprazole

    Case report 05 September 2015 Pages: 35 - 35

36. Asparaginase

    Case report 05 September 2015 Pages: 36 - 36

37. Aspirin

    Case report 05 September 2015 Pages: 37 - 37

38. Aspirin/clopidogrel

    Case report 05 September 2015 Pages: 38 - 38

39. Atorvastatin/fluvastatin/simvastatin

    Case report 05 September 2015 Pages: 39 - 39

40. Atorvastatin/rosuvastatin/simuvastatin

    Case report 05 September 2015 Pages: 40 - 40

41. Baclofen

    Case report 05 September 2015 Pages: 41 - 41

42. Betamethasone

    Case report 05 September 2015 Pages: 42 - 42

43. Bevacizumab/carboplatin/paclitaxel

    Case report 05 September 2015 Pages: 43 - 43

44. Brimonidine

    Case report 05 September 2015 Pages: 44 - 44

45. Bupivacaine/fentanyl

    Case report 05 September 2015 Pages: 45 - 45

46. Bupivacaine/fentanyl

    Case report 05 September 2015 Pages: 46 - 46

47. Butalbital

    Case report 05 September 2015 Pages: 47 - 47

48. Calcium carbonate/canagliflozin

    Case report 05 September 2015 Pages: 48 - 48

49. Capecitabine

    Case report 05 September 2015 Pages: 49 - 49

50. Capecitabine

    Case report 05 September 2015 Pages: 50 - 50